Article Details

Insilico Medicine enters AI-driven R&D to fight age-related CNS diseases and aging

Retrieved on: 2021-09-02 10:00:40

Tags for this article:

Click the tags to see associated articles and topics

Insilico Medicine enters AI-driven R&D to fight age-related CNS diseases and aging. View article details on hiswai:

Excerpt

Insilico Medicine inks an R&D collaboration with Gray Matter, a longevity biotechnology company focused on peptide-based interventions against cognitive ...

Article found on: www.biospectrumasia.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up